

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.39973803 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.39973803 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.39973803 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.39973803 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.39973803 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.39973803 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.24526190 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.01853637 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.79965328 |
| 10 | microglial cell activation (GO:0001774) | 5.43016959 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 4.91022863 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.85744443 |
| 13 | response to host immune response (GO:0052572) | 4.74546533 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.74546533 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.61462542 |
| 16 | amino sugar catabolic process (GO:0046348) | 4.56334657 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.52821614 |
| 18 | response to host (GO:0075136) | 4.42288466 |
| 19 | response to host defenses (GO:0052200) | 4.42288466 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.42288466 |
| 21 | ceramide catabolic process (GO:0046514) | 4.27791851 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.26850167 |
| 23 | macrophage activation (GO:0042116) | 4.09403625 |
| 24 | barbed-end actin filament capping (GO:0051016) | 4.08672590 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.84597717 |
| 26 | apoptotic cell clearance (GO:0043277) | 3.78355780 |
| 27 | response to peptidoglycan (GO:0032494) | 3.74162470 |
| 28 | keratan sulfate catabolic process (GO:0042340) | 3.72103242 |
| 29 | mannose metabolic process (GO:0006013) | 3.65173422 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61597135 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.60488518 |
| 32 | membrane lipid catabolic process (GO:0046466) | 3.55974482 |
| 33 | respiratory burst (GO:0045730) | 3.52961144 |
| 34 | myeloid cell activation involved in immune response (GO:0002275) | 3.52608425 |
| 35 | sphingolipid catabolic process (GO:0030149) | 3.51617241 |
| 36 | N-acetylneuraminate metabolic process (GO:0006054) | 3.44874532 |
| 37 | protein localization to endosome (GO:0036010) | 3.44661968 |
| 38 | I-kappaB phosphorylation (GO:0007252) | 3.43598626 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.41317152 |
| 40 | regulation of cholesterol storage (GO:0010885) | 3.41110792 |
| 41 | regulation of mononuclear cell migration (GO:0071675) | 3.35574996 |
| 42 | hyaluronan catabolic process (GO:0030214) | 3.32440708 |
| 43 | pinocytosis (GO:0006907) | 3.30934401 |
| 44 | low-density lipoprotein particle clearance (GO:0034383) | 3.26680558 |
| 45 | cell adhesion mediated by integrin (GO:0033627) | 3.19388721 |
| 46 | peptide catabolic process (GO:0043171) | 3.17744612 |
| 47 | regulation of superoxide anion generation (GO:0032928) | 3.15476151 |
| 48 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.13629467 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.11217117 |
| 50 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.10486626 |
| 51 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.08814959 |
| 52 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.05718679 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.05288511 |
| 54 | positive regulation of cholesterol efflux (GO:0010875) | 3.05189420 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04829850 |
| 56 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.03704387 |
| 57 | glycosphingolipid catabolic process (GO:0046479) | 3.03399608 |
| 58 | granulocyte activation (GO:0036230) | 3.03252165 |
| 59 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.01679810 |
| 60 | positive regulation of chemokine secretion (GO:0090197) | 2.99199950 |
| 61 | negative regulation of granulocyte differentiation (GO:0030853) | 2.97639607 |
| 62 | adhesion of symbiont to host (GO:0044406) | 2.96240772 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 2.95310068 |
| 64 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.93615526 |
| 65 | positive regulation of mast cell activation (GO:0033005) | 2.91690436 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 2.90861835 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 2.90423849 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90377396 |
| 69 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90269232 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 2.89213235 |
| 71 | neutrophil activation (GO:0042119) | 2.89162347 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 2.88306283 |
| 73 | positive regulation of leukocyte degranulation (GO:0043302) | 2.87761209 |
| 74 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86610002 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 2.86604263 |
| 76 | negative regulation of interleukin-17 production (GO:0032700) | 2.86243524 |
| 77 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.85090299 |
| 78 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83646271 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.82715817 |
| 80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81767567 |
| 81 | detection of other organism (GO:0098543) | 2.77741478 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.76539644 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 2.74341497 |
| 84 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74193581 |
| 85 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73138433 |
| 86 | glycolipid catabolic process (GO:0019377) | 2.71424523 |
| 87 | regulation of macrophage chemotaxis (GO:0010758) | 2.70142142 |
| 88 | regulation of macrophage cytokine production (GO:0010935) | 2.70051299 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69151013 |
| 90 | cellular extravasation (GO:0045123) | 2.68969787 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 2.68488384 |
| 92 | response to laminar fluid shear stress (GO:0034616) | 2.68349412 |
| 93 | lytic vacuole organization (GO:0080171) | 2.68335610 |
| 94 | lysosome organization (GO:0007040) | 2.68335610 |
| 95 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.68312364 |
| 96 | detection of external biotic stimulus (GO:0098581) | 2.67791056 |
| 97 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.66878867 |
| 98 | regulation of mast cell activation (GO:0033003) | 2.66705530 |
| 99 | response to muramyl dipeptide (GO:0032495) | 2.66345930 |
| 100 | regulation of podosome assembly (GO:0071801) | 2.66150218 |
| 101 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.65947409 |
| 102 | negative regulation of mast cell activation (GO:0033004) | 2.65837951 |
| 103 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.62771674 |
| 104 | response to thyroid hormone (GO:0097066) | 2.62089641 |
| 105 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60477655 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60387463 |
| 107 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60387463 |
| 108 | detection of bacterium (GO:0016045) | 2.60379407 |
| 109 | positive regulation of chemokine production (GO:0032722) | 2.59787827 |
| 110 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.58968932 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58684016 |
| 112 | regulation of monocyte chemotaxis (GO:0090025) | 2.57903897 |
| 113 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57308607 |
| 114 | negative regulation of cell killing (GO:0031342) | 2.57308607 |
| 115 | phagosome maturation (GO:0090382) | 2.57206458 |
| 116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57086870 |
| 117 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.55885752 |
| 118 | myeloid leukocyte activation (GO:0002274) | 2.53859718 |
| 119 | response to acidic pH (GO:0010447) | 2.53373689 |
| 120 | negative regulation of lipid storage (GO:0010888) | 2.52887553 |
| 121 | positive regulation of extracellular matrix organization (GO:1903055) | 2.51994402 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 2.49896095 |
| 123 | positive regulation of bone remodeling (GO:0046852) | 2.49755206 |
| 124 | positive regulation of bone resorption (GO:0045780) | 2.49755206 |
| 125 | decidualization (GO:0046697) | 2.49315867 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.49271891 |
| 127 | cellular response to arsenic-containing substance (GO:0071243) | 2.48896726 |
| 128 | macrophage differentiation (GO:0030225) | 2.48644014 |
| 129 | positive regulation of cholesterol transport (GO:0032376) | 2.48420186 |
| 130 | positive regulation of sterol transport (GO:0032373) | 2.48420186 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 2.47903843 |
| 132 | phospholipid efflux (GO:0033700) | 2.47847558 |
| 133 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.47797219 |
| 134 | regulation of regulated secretory pathway (GO:1903305) | 2.47737907 |
| 135 | adenosine receptor signaling pathway (GO:0001973) | 2.47644246 |
| 136 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.46874648 |
| 137 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46651461 |
| 138 | angiotensin maturation (GO:0002003) | 2.46260373 |
| 139 | response to magnesium ion (GO:0032026) | 2.45667634 |
| 140 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.44983757 |
| 141 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.44983757 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.44734638 |
| 143 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.44734638 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.44326153 |
| 145 | monocyte chemotaxis (GO:0002548) | 2.44140205 |
| 146 | response to lipoprotein particle (GO:0055094) | 2.44004874 |
| 147 | adhesion of symbiont to host cell (GO:0044650) | 2.43396216 |
| 148 | virion attachment to host cell (GO:0019062) | 2.43396216 |
| 149 | substrate-dependent cell migration (GO:0006929) | 2.43051277 |
| 150 | germinal center formation (GO:0002467) | 2.42883981 |
| 151 | B cell mediated immunity (GO:0019724) | 2.40690880 |
| 152 | cellular response to interferon-alpha (GO:0035457) | 2.39835015 |
| 153 | neutrophil chemotaxis (GO:0030593) | 2.38094908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.27787613 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.84074172 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.45525549 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.96293978 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.81253117 |
| 6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.45097585 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44145093 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.05040004 |
| 9 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.97440947 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78873960 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.77394084 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.68566386 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32786199 |
| 14 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25938087 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.21523747 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19122389 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.13817108 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06956742 |
| 19 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03698095 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03337829 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.00611916 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.95987959 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93337911 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87493244 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87060624 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82906177 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79429822 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72970801 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71919885 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69830803 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68733752 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68009077 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67714305 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64202493 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63708204 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61172450 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57651938 |
| 38 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.56453116 |
| 39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54944112 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53479772 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53138519 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53104478 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52092172 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49235096 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48592306 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45887331 |
| 47 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45564731 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45463018 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45023156 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44380342 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42701061 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40419827 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40042013 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.38965957 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35612994 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35609964 |
| 57 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35136903 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33582219 |
| 59 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.33419759 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32391039 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30925486 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30552096 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29239479 |
| 64 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27413925 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26731802 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.26600041 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26175551 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24355904 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.24293067 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23008208 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22953787 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22285482 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21959954 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20581287 |
| 75 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18388044 |
| 76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17795220 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17480714 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16871783 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16193598 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15920130 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14991467 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13805345 |
| 83 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13527219 |
| 84 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.13499770 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13057973 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12736679 |
| 87 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.12632195 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12173640 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11489142 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10483805 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10076271 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09766323 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09691534 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09660124 |
| 95 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08091249 |
| 96 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07694027 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07671930 |
| 98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06523863 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05862898 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05404581 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05193134 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04899885 |
| 103 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04805523 |
| 104 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.04354186 |
| 105 | P68_20966046_ChIP-Seq_HELA_Human | 1.04334730 |
| 106 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.03937118 |
| 107 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03260315 |
| 108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03071317 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02336504 |
| 110 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02334443 |
| 111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02106934 |
| 112 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.01869750 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00820651 |
| 114 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00698122 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.00294389 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00176749 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99095089 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98024915 |
| 119 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95082287 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94589158 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94589158 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 0.94467992 |
| 123 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93531792 |
| 124 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93191655 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92948606 |
| 126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92186962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.50000655 |
| 2 | MP0006082_CNS_inflammation | 3.54395537 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.38651795 |
| 4 | MP0003303_peritoneal_inflammation | 3.29362950 |
| 5 | MP0003436_decreased_susceptibility_to | 3.04469964 |
| 6 | MP0009840_abnormal_foam_cell | 3.01806695 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.75960213 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.64773977 |
| 9 | * MP0003172_abnormal_lysosome_physiology | 2.63917872 |
| 10 | MP0002419_abnormal_innate_immunity | 2.63688472 |
| 11 | * MP0001835_abnormal_antigen_presentation | 2.46295139 |
| 12 | MP0005451_abnormal_body_composition | 2.31881307 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.25874013 |
| 14 | MP0003690_abnormal_glial_cell | 2.13742282 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.13631063 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.12375012 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.08208442 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.07573452 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.05287469 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.03858063 |
| 21 | MP0000604_amyloidosis | 1.98950966 |
| 22 | MP0000343_altered_response_to | 1.97334604 |
| 23 | MP0009785_altered_susceptibility_to | 1.95800080 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.95770561 |
| 25 | MP0003329_amyloid_beta_deposits | 1.90781100 |
| 26 | MP0005025_abnormal_response_to | 1.87572379 |
| 27 | MP0003075_altered_response_to | 1.87391194 |
| 28 | MP0004510_myositis | 1.87335252 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.86592160 |
| 30 | MP0003724_increased_susceptibility_to | 1.83217063 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.70137001 |
| 32 | MP0008260_abnormal_autophagy | 1.68532511 |
| 33 | MP0003448_altered_tumor_morphology | 1.66697507 |
| 34 | MP0001958_emphysema | 1.65159138 |
| 35 | MP0001790_abnormal_immune_system | 1.64652814 |
| 36 | MP0005387_immune_system_phenotype | 1.64652814 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.63146614 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.61768450 |
| 39 | MP0004947_skin_inflammation | 1.60405983 |
| 40 | MP0002723_abnormal_immune_serum | 1.59871499 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.52917778 |
| 42 | MP0005671_abnormal_response_to | 1.50920744 |
| 43 | MP0001819_abnormal_immune_cell | 1.46959256 |
| 44 | MP0001800_abnormal_humoral_immune | 1.44902510 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.44647502 |
| 46 | MP0009278_abnormal_bone_marrow | 1.43309908 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.42098392 |
| 48 | MP0005365_abnormal_bile_salt | 1.41614859 |
| 49 | MP0005166_decreased_susceptibility_to | 1.40806005 |
| 50 | MP0008469_abnormal_protein_level | 1.39009969 |
| 51 | MP0002405_respiratory_system_inflammati | 1.38592927 |
| 52 | MP0000858_altered_metastatic_potential | 1.38234262 |
| 53 | MP0010307_abnormal_tumor_latency | 1.36717187 |
| 54 | MP0004130_abnormal_muscle_cell | 1.35622709 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.34914094 |
| 56 | MP0000685_abnormal_immune_system | 1.34482493 |
| 57 | MP0001849_ear_inflammation | 1.25628438 |
| 58 | MP0005310_abnormal_salivary_gland | 1.25110574 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.24645748 |
| 60 | MP0003279_aneurysm | 1.23901367 |
| 61 | MP0001851_eye_inflammation | 1.20302343 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.16333718 |
| 63 | MP0002254_reproductive_system_inflammat | 1.13767466 |
| 64 | MP0001853_heart_inflammation | 1.12923893 |
| 65 | MP0002933_joint_inflammation | 1.12434206 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.12173946 |
| 67 | MP0005023_abnormal_wound_healing | 1.11704685 |
| 68 | MP0003828_pulmonary_edema | 1.11554056 |
| 69 | MP0005275_abnormal_skin_tensile | 1.11520862 |
| 70 | MP0009764_decreased_sensitivity_to | 1.10742864 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.09629737 |
| 72 | MP0005390_skeleton_phenotype | 1.09497379 |
| 73 | MP0003091_abnormal_cell_migration | 1.07022054 |
| 74 | MP0005164_abnormal_response_to | 1.04712818 |
| 75 | MP0004858_abnormal_nervous_system | 0.98868482 |
| 76 | MP0009333_abnormal_splenocyte_physiolog | 0.98593127 |
| 77 | MP0005670_abnormal_white_adipose | 0.97765102 |
| 78 | MP0000249_abnormal_blood_vessel | 0.95964968 |
| 79 | MP0003045_fibrosis | 0.94375128 |
| 80 | * MP0000716_abnormal_immune_system | 0.94024494 |
| 81 | MP0010155_abnormal_intestine_physiology | 0.92193327 |
| 82 | * MP0003634_abnormal_glial_cell | 0.91437192 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.91180299 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.90111223 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.89724995 |
| 86 | * MP0000689_abnormal_spleen_morphology | 0.89520844 |
| 87 | MP0004883_abnormal_blood_vessel | 0.88772424 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.88214102 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.87382094 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.87382094 |
| 91 | MP0003795_abnormal_bone_structure | 0.85771861 |
| 92 | MP0001542_abnormal_bone_strength | 0.84528818 |
| 93 | MP0005165_increased_susceptibility_to | 0.83534662 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.82896232 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.82604283 |
| 96 | MP0000371_diluted_coat_color | 0.81849807 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.80756165 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.79885437 |
| 99 | MP0003879_abnormal_hair_cell | 0.78144634 |
| 100 | MP0002006_tumorigenesis | 0.77589607 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.77127323 |
| 102 | * MP0002429_abnormal_blood_cell | 0.76288455 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.75408834 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.74287757 |
| 105 | * MP0002398_abnormal_bone_marrow | 0.73108033 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.72499208 |
| 107 | MP0009763_increased_sensitivity_to | 0.72421394 |
| 108 | MP0004264_abnormal_extraembryonic_tissu | 0.71724631 |
| 109 | * MP0002722_abnormal_immune_system | 0.71484419 |
| 110 | MP0000609_abnormal_liver_physiology | 0.71194433 |
| 111 | * MP0002090_abnormal_vision | 0.70865220 |
| 112 | MP0008004_abnormal_stomach_pH | 0.70519602 |
| 113 | MP0000920_abnormal_myelination | 0.70343941 |
| 114 | MP0001915_intracranial_hemorrhage | 0.70274832 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.69954797 |
| 116 | MP0006054_spinal_hemorrhage | 0.69398375 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.67790629 |
| 118 | MP0000747_muscle_weakness | 0.65922574 |
| 119 | MP0005360_urolithiasis | 0.65320336 |
| 120 | MP0001663_abnormal_digestive_system | 0.64931419 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64818097 |
| 122 | MP0002796_impaired_skin_barrier | 0.61927855 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.61605556 |
| 124 | MP0008874_decreased_physiological_sensi | 0.61577001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.98793406 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.74952717 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.63106292 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.63106292 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.63106292 |
| 6 | Dysostosis multiplex (HP:0000943) | 5.52960486 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.27994426 |
| 8 | * Increased cerebral lipofuscin (HP:0011813) | 5.23480891 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.81662855 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.54515094 |
| 11 | Mucopolysacchariduria (HP:0008155) | 4.54515094 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.49673933 |
| 13 | Glomerulonephritis (HP:0000099) | 4.40607330 |
| 14 | Axonal loss (HP:0003447) | 4.39641326 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30756960 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.27661740 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.27661740 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.27661740 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.23223209 |
| 20 | Disinhibition (HP:0000734) | 4.07176223 |
| 21 | * Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.89154120 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.58856438 |
| 23 | Nuclear cataract (HP:0100018) | 3.54497884 |
| 24 | Cerebral aneurysm (HP:0004944) | 3.50812759 |
| 25 | Complement deficiency (HP:0004431) | 3.30935596 |
| 26 | Loss of speech (HP:0002371) | 3.25739728 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.18909598 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.14376045 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 3.06245325 |
| 30 | Hematochezia (HP:0002573) | 2.95313133 |
| 31 | Purpura (HP:0000979) | 2.94878025 |
| 32 | Nephritis (HP:0000123) | 2.90344267 |
| 33 | Abnormality of complement system (HP:0005339) | 2.86713974 |
| 34 | Arterial tortuosity (HP:0005116) | 2.83881332 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.79680835 |
| 36 | Gingivitis (HP:0000230) | 2.79188111 |
| 37 | Agnosia (HP:0010524) | 2.78806461 |
| 38 | Myocardial infarction (HP:0001658) | 2.78015306 |
| 39 | Upper motor neuron abnormality (HP:0002127) | 2.69430646 |
| 40 | Vascular tortuosity (HP:0004948) | 2.69023264 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.65731574 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.61392237 |
| 43 | Mutism (HP:0002300) | 2.53151673 |
| 44 | Recurrent skin infections (HP:0001581) | 2.49444501 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.48748019 |
| 46 | Increased serum ferritin (HP:0003281) | 2.47936355 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.47450805 |
| 48 | Pathologic fracture (HP:0002756) | 2.47252705 |
| 49 | Aortic aneurysm (HP:0004942) | 2.47100606 |
| 50 | Prolonged neonatal jaundice (HP:0006579) | 2.44824044 |
| 51 | Abnormality of the lumbar spine (HP:0100712) | 2.40668205 |
| 52 | Myositis (HP:0100614) | 2.37713076 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 2.36448871 |
| 54 | Diminished motivation (HP:0000745) | 2.35780837 |
| 55 | Apathy (HP:0000741) | 2.34724660 |
| 56 | Thoracic kyphosis (HP:0002942) | 2.34579815 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.32592423 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32063394 |
| 59 | Obstructive lung disease (HP:0006536) | 2.32063394 |
| 60 | Xanthomatosis (HP:0000991) | 2.30938689 |
| 61 | Basal ganglia calcification (HP:0002135) | 2.30666254 |
| 62 | Dementia (HP:0000726) | 2.28440298 |
| 63 | Aortic dissection (HP:0002647) | 2.27947179 |
| 64 | Spondylolisthesis (HP:0003302) | 2.27242104 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.26805341 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.26805341 |
| 67 | Increased CSF protein (HP:0002922) | 2.24060185 |
| 68 | Distal lower limb muscle weakness (HP:0009053) | 2.22793274 |
| 69 | Cervical subluxation (HP:0003308) | 2.21979309 |
| 70 | Ovoid vertebral bodies (HP:0003300) | 2.19441739 |
| 71 | Tetraparesis (HP:0002273) | 2.19435786 |
| 72 | Premature rupture of membranes (HP:0001788) | 2.18246747 |
| 73 | Peripheral demyelination (HP:0011096) | 2.18240882 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.17780774 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16111214 |
| 76 | Conjunctival telangiectasia (HP:0000524) | 2.14525731 |
| 77 | Orchitis (HP:0100796) | 2.11475403 |
| 78 | Striae distensae (HP:0001065) | 2.10475940 |
| 79 | Thick nail (HP:0001805) | 2.06469878 |
| 80 | Pustule (HP:0200039) | 2.06341548 |
| 81 | Joint stiffness (HP:0001387) | 2.05858014 |
| 82 | Global brain atrophy (HP:0002283) | 2.04945964 |
| 83 | Bone pain (HP:0002653) | 2.03080886 |
| 84 | Bone cyst (HP:0012062) | 2.02166255 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.01194004 |
| 86 | Malnutrition (HP:0004395) | 1.99222290 |
| 87 | Cellulitis (HP:0100658) | 1.98077679 |
| 88 | Abnormality of the periventricular white matter (HP:0002518) | 1.97382634 |
| 89 | Personality changes (HP:0000751) | 1.97071117 |
| 90 | Petechiae (HP:0000967) | 1.95941806 |
| 91 | Frequent falls (HP:0002359) | 1.93811737 |
| 92 | Inappropriate behavior (HP:0000719) | 1.92355036 |
| 93 | Abnormality of the nasal mucosa (HP:0000433) | 1.92336188 |
| 94 | Periodontitis (HP:0000704) | 1.91702542 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.89387324 |
| 96 | Metaphyseal irregularity (HP:0003025) | 1.88974264 |
| 97 | Urticaria (HP:0001025) | 1.88421945 |
| 98 | Neurofibrillary tangles (HP:0002185) | 1.87608337 |
| 99 | Mucosal telangiectasiae (HP:0100579) | 1.86881739 |
| 100 | Progressive visual loss (HP:0000529) | 1.85600993 |
| 101 | Osteomyelitis (HP:0002754) | 1.82178774 |
| 102 | Supranuclear gaze palsy (HP:0000605) | 1.80558714 |
| 103 | Spontaneous hematomas (HP:0007420) | 1.80197006 |
| 104 | Disproportionate tall stature (HP:0001519) | 1.78355412 |
| 105 | * Neuronal loss in central nervous system (HP:0002529) | 1.76486775 |
| 106 | Achilles tendon contracture (HP:0001771) | 1.76425009 |
| 107 | Amyloidosis (HP:0011034) | 1.75168002 |
| 108 | Beaking of vertebral bodies (HP:0004568) | 1.73326167 |
| 109 | Abnormality of the thoracic spine (HP:0100711) | 1.72998904 |
| 110 | Cardiomegaly (HP:0001640) | 1.70792209 |
| 111 | Thin bony cortex (HP:0002753) | 1.69783970 |
| 112 | Protuberant abdomen (HP:0001538) | 1.69245683 |
| 113 | Stomatitis (HP:0010280) | 1.69073454 |
| 114 | Skin nodule (HP:0200036) | 1.64775783 |
| 115 | Hand muscle atrophy (HP:0009130) | 1.64076071 |
| 116 | Colitis (HP:0002583) | 1.63774086 |
| 117 | Mitral valve prolapse (HP:0001634) | 1.63020528 |
| 118 | Pulmonary infiltrates (HP:0002113) | 1.62656378 |
| 119 | Abnormality of the Achilles tendon (HP:0005109) | 1.62339187 |
| 120 | Restrictive lung disease (HP:0002091) | 1.61528920 |
| 121 | Deformed sella turcica (HP:0002681) | 1.61385430 |
| 122 | Distal upper limb amyotrophy (HP:0007149) | 1.61234948 |
| 123 | Upper limb amyotrophy (HP:0009129) | 1.61234948 |
| 124 | Retrobulbar optic neuritis (HP:0100654) | 1.60942145 |
| 125 | Optic neuritis (HP:0100653) | 1.60942145 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59654113 |
| 127 | Deep venous thrombosis (HP:0002625) | 1.55820080 |
| 128 | Bulbar palsy (HP:0001283) | 1.54383097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.79250117 |
| 2 | TRIB3 | 3.58873159 |
| 3 | ERN1 | 3.42096404 |
| 4 | TBK1 | 2.86691081 |
| 5 | PKN2 | 2.74263616 |
| 6 | RIPK4 | 2.57558471 |
| 7 | BLK | 2.55604035 |
| 8 | TYK2 | 2.54799819 |
| 9 | KIT | 2.35432057 |
| 10 | TTN | 2.27980024 |
| 11 | PRPF4B | 2.27288953 |
| 12 | CSF1R | 2.19598036 |
| 13 | CAMK1D | 2.13818956 |
| 14 | TAOK2 | 2.12528609 |
| 15 | TESK2 | 1.98436091 |
| 16 | PAK4 | 1.94815905 |
| 17 | DDR2 | 1.94064854 |
| 18 | MAP4K1 | 1.90447099 |
| 19 | IRAK3 | 1.77321486 |
| 20 | JAK1 | 1.77274054 |
| 21 | NEK9 | 1.71721214 |
| 22 | TAOK1 | 1.71063494 |
| 23 | EPHB1 | 1.64732858 |
| 24 | IRAK4 | 1.58824522 |
| 25 | RIPK1 | 1.57334341 |
| 26 | STK10 | 1.53487382 |
| 27 | SCYL2 | 1.53345926 |
| 28 | PTK6 | 1.52229820 |
| 29 | ZAP70 | 1.51583842 |
| 30 | MAP2K3 | 1.47398493 |
| 31 | EPHA2 | 1.42221449 |
| 32 | GRK7 | 1.41318473 |
| 33 | CDC42BPA | 1.39973808 |
| 34 | ICK | 1.39501968 |
| 35 | MAP3K14 | 1.38659490 |
| 36 | CAMK1G | 1.36399613 |
| 37 | LRRK2 | 1.36190603 |
| 38 | HCK | 1.32599283 |
| 39 | CSK | 1.29861462 |
| 40 | MAP3K3 | 1.22883063 |
| 41 | CAMKK2 | 1.22250723 |
| 42 | LIMK1 | 1.21573707 |
| 43 | JAK2 | 1.15456423 |
| 44 | IKBKB | 1.15294835 |
| 45 | MATK | 1.09645936 |
| 46 | BMX | 1.08192533 |
| 47 | PIM2 | 1.05929202 |
| 48 | ARAF | 1.05135285 |
| 49 | JAK3 | 1.02315172 |
| 50 | IKBKE | 1.01801231 |
| 51 | FGR | 1.01530043 |
| 52 | MOS | 1.00732275 |
| 53 | CAMKK1 | 0.99683646 |
| 54 | MAPK15 | 0.97754233 |
| 55 | SMG1 | 0.97734710 |
| 56 | TRPM7 | 0.95622930 |
| 57 | FES | 0.95212957 |
| 58 | PDK2 | 0.92198280 |
| 59 | SYK | 0.88675518 |
| 60 | ITK | 0.87715893 |
| 61 | LCK | 0.85959207 |
| 62 | LYN | 0.82013198 |
| 63 | SIK3 | 0.80067890 |
| 64 | RPS6KA4 | 0.78720708 |
| 65 | KSR2 | 0.78179677 |
| 66 | NME2 | 0.76693162 |
| 67 | CDK6 | 0.75432783 |
| 68 | MAP3K6 | 0.75262562 |
| 69 | IRAK2 | 0.75229546 |
| 70 | ACVR1B | 0.74049456 |
| 71 | TESK1 | 0.73413143 |
| 72 | EGFR | 0.72945304 |
| 73 | TAOK3 | 0.71354716 |
| 74 | EPHB2 | 0.71215181 |
| 75 | FGFR4 | 0.71210501 |
| 76 | PDGFRA | 0.70276042 |
| 77 | ABL2 | 0.70112419 |
| 78 | SIK1 | 0.69234534 |
| 79 | PAK2 | 0.69181989 |
| 80 | BTK | 0.67422039 |
| 81 | PRKD2 | 0.66550086 |
| 82 | RPS6KC1 | 0.64779500 |
| 83 | RPS6KL1 | 0.64779500 |
| 84 | MAP3K11 | 0.63484201 |
| 85 | PRKCH | 0.62449912 |
| 86 | PDPK1 | 0.61880646 |
| 87 | MST1R | 0.61424557 |
| 88 | MAP2K6 | 0.58289824 |
| 89 | GRK6 | 0.57701619 |
| 90 | MAP3K10 | 0.57494614 |
| 91 | RET | 0.57307937 |
| 92 | FGFR3 | 0.57291355 |
| 93 | DMPK | 0.56737454 |
| 94 | MARK3 | 0.56081026 |
| 95 | PRKCD | 0.55329750 |
| 96 | PDGFRB | 0.55276955 |
| 97 | MAP3K13 | 0.55152333 |
| 98 | ABL1 | 0.54366090 |
| 99 | EEF2K | 0.54279039 |
| 100 | PDK1 | 0.53416890 |
| 101 | MAP3K2 | 0.52148320 |
| 102 | KDR | 0.51495444 |
| 103 | MARK2 | 0.51398241 |
| 104 | MAPK12 | 0.48665232 |
| 105 | CHUK | 0.48648745 |
| 106 | MAPKAPK2 | 0.48302755 |
| 107 | CLK1 | 0.47959596 |
| 108 | IGF1R | 0.47906992 |
| 109 | TXK | 0.47466423 |
| 110 | MAPK7 | 0.46094088 |
| 111 | PTK2 | 0.46016265 |
| 112 | PBK | 0.45744545 |
| 113 | MAP3K5 | 0.45493288 |
| 114 | RPS6KA6 | 0.45391086 |
| 115 | LMTK2 | 0.45227270 |
| 116 | PIK3CG | 0.45015325 |
| 117 | GSK3A | 0.44485117 |
| 118 | FYN | 0.43615282 |
| 119 | HIPK2 | 0.40580205 |
| 120 | MAPK4 | 0.40165378 |
| 121 | TNK2 | 0.40024271 |
| 122 | MAPKAPK3 | 0.39877524 |
| 123 | RPS6KA2 | 0.39861332 |
| 124 | MAP3K1 | 0.39762452 |
| 125 | PRKD1 | 0.39358058 |
| 126 | PRKG2 | 0.39136301 |
| 127 | DAPK3 | 0.38928039 |
| 128 | SRC | 0.37054315 |
| 129 | MAP3K8 | 0.37034902 |
| 130 | LATS2 | 0.36589985 |
| 131 | MAP2K2 | 0.36164281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.32875094 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 3.92668070 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.72638019 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.68198689 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.71019951 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42610334 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.15277754 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.14044777 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.11728132 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04596046 |
| 11 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.00427256 |
| 12 | * Tuberculosis_Homo sapiens_hsa05152 | 1.93365040 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.85651647 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79372814 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.77441438 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61307873 |
| 17 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60700003 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51875693 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49155006 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43276258 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.36333442 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34677539 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.28068697 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27937154 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22416461 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.20065621 |
| 27 | Amoebiasis_Homo sapiens_hsa05146 | 1.18091792 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18006496 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15468803 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14191297 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.13837354 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12622546 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.11904736 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11668025 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10894847 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.10347070 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08543094 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08210451 |
| 39 | * Apoptosis_Homo sapiens_hsa04210 | 1.07367089 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06568858 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03665258 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03020324 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.02456785 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99903717 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97365369 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97126450 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93488161 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93023294 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90129492 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89056034 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88467770 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.85948570 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85547506 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85268914 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.81915868 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79580533 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78511719 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.78251080 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77152977 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.77029999 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72811803 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69521199 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69072369 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68176785 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67758379 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67465579 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66800667 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65952094 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65619808 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64483943 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63826567 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.63778034 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61577886 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60951163 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.59359594 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58909561 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56566766 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56327507 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.56275353 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54905053 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.54427685 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.52455189 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50733615 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.49342405 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48972092 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48927090 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46913818 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46620242 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44826648 |
| 90 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44242953 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42275349 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40822265 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40378084 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40132004 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40057491 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39018284 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38209123 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.37917664 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37785470 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37188313 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36616345 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36506632 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36193119 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34946479 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.34865206 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33843779 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32607358 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32199372 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31035711 |
| 110 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30944323 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30144639 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30072534 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29568849 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29177018 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27682934 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27280668 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26908949 |
| 118 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23548637 |

